Search

James William Rogers

Examiner (ID: 18141, Phone: (571)272-7838 , Office: P/1618 )

Most Active Art Unit
1618
Art Unit(s)
1618
Total Applications
1196
Issued Applications
505
Pending Applications
144
Abandoned Applications
587

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17198483 [patent_doc_number] => 20210338577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => BIO-INSPIRED DEGRADABLE TOUGH ADHESIVES FOR DIVERSE WET SURFACES [patent_app_type] => utility [patent_app_number] => 17/283412 [patent_app_country] => US [patent_app_date] => 2019-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14936 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283412 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/283412
BIO-INSPIRED DEGRADABLE TOUGH ADHESIVES FOR DIVERSE WET SURFACES Oct 10, 2019 Abandoned
Array ( [id] => 17170332 [patent_doc_number] => 20210324002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => TERTIARY AMINO LIPIDATED CATIONIC PEPTIDES FOR NUCLEIC ACID DELIVERY [patent_app_type] => utility [patent_app_number] => 17/279508 [patent_app_country] => US [patent_app_date] => 2019-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23680 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17279508 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/279508
TERTIARY AMINO LIPIDATED CATIONIC PEPTIDES FOR NUCLEIC ACID DELIVERY Sep 26, 2019 Abandoned
Array ( [id] => 17198740 [patent_doc_number] => 20210338834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => DEGRADABLE HYALURONIC ACID HYDROGELS [patent_app_type] => utility [patent_app_number] => 17/280760 [patent_app_country] => US [patent_app_date] => 2019-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 91857 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 457 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17280760 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/280760
DEGRADABLE HYALURONIC ACID HYDROGELS Sep 24, 2019 Pending
Array ( [id] => 19011758 [patent_doc_number] => 11918659 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-05 [patent_title] => Materials and methods for inducing therapeutic hypothermia in a mammalian subject [patent_app_type] => utility [patent_app_number] => 17/277775 [patent_app_country] => US [patent_app_date] => 2019-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 6612 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17277775 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/277775
Materials and methods for inducing therapeutic hypothermia in a mammalian subject Sep 18, 2019 Issued
Array ( [id] => 19104634 [patent_doc_number] => 11957707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-16 [patent_title] => Compositions and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/573559 [patent_app_country] => US [patent_app_date] => 2019-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 23346 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16573559 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/573559
Compositions and methods of use thereof Sep 16, 2019 Issued
Array ( [id] => 15586131 [patent_doc_number] => 20200069600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-05 [patent_title] => DELIVERY OF DRUG NANOPARTICLES AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/567164 [patent_app_country] => US [patent_app_date] => 2019-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26689 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16567164 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/567164
Delivery of drug nanoparticles and methods of use thereof Sep 10, 2019 Issued
Array ( [id] => 17368398 [patent_doc_number] => 20220023450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => BONE MARROW-, RETICULOENDOTHELIAL SYSTEM-, AND/OR LYMPH NODE-TARGETED RADIOLABELED LIPOSOMES AND METHODS OF THEIR DIAGNOSTIC AND THERAPEUTIC USE [patent_app_type] => utility [patent_app_number] => 17/274952 [patent_app_country] => US [patent_app_date] => 2019-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17112 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -103 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17274952 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/274952
BONE MARROW-, RETICULOENDOTHELIAL SYSTEM-, AND/OR LYMPH NODE-TARGETED RADIOLABELED LIPOSOMES AND METHODS OF THEIR DIAGNOSTIC AND THERAPEUTIC USE Sep 9, 2019 Pending
Array ( [id] => 17168898 [patent_doc_number] => 20210322568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => Virucidal Nanoparticles And Use Thereof Against Influenza Virus [patent_app_type] => utility [patent_app_number] => 17/273113 [patent_app_country] => US [patent_app_date] => 2019-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12307 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17273113 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/273113
Virucidal Nanoparticles And Use Thereof Against Influenza Virus Sep 2, 2019 Abandoned
Array ( [id] => 15556709 [patent_doc_number] => 20200062766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-27 [patent_title] => COELENTERAZINE ANALOGUES [patent_app_type] => utility [patent_app_number] => 16/548214 [patent_app_country] => US [patent_app_date] => 2019-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21673 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16548214 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/548214
Coelenterazine analogues Aug 21, 2019 Issued
Array ( [id] => 17227223 [patent_doc_number] => 20210353779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => GOLD NANOPARTICLE-LIGAND CONJUGATES AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/269113 [patent_app_country] => US [patent_app_date] => 2019-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14368 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269113 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/269113
Gold nanoparticle-ligand conjugates and methods of use Aug 19, 2019 Issued
Array ( [id] => 15206493 [patent_doc_number] => 20190365933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-05 [patent_title] => SOLVENT-FREE GADOLINIUM CONTRAST AGENTS [patent_app_type] => utility [patent_app_number] => 16/537906 [patent_app_country] => US [patent_app_date] => 2019-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8709 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16537906 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/537906
Solvent-free gadolinium contrast agents Aug 11, 2019 Issued
Array ( [id] => 20187131 [patent_doc_number] => 12398236 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-26 [patent_title] => Absorbable copolymers with improved thermal stability [patent_app_type] => utility [patent_app_number] => 16/536093 [patent_app_country] => US [patent_app_date] => 2019-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 6732 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16536093 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/536093
Absorbable copolymers with improved thermal stability Aug 7, 2019 Issued
Array ( [id] => 15114415 [patent_doc_number] => 20190343840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-14 [patent_title] => RISPERIDONE SUSTAINED RELEASE MICROSPHERE COMPOSITION [patent_app_type] => utility [patent_app_number] => 16/525502 [patent_app_country] => US [patent_app_date] => 2019-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7417 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16525502 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/525502
Risperidone sustained release microsphere composition Jul 28, 2019 Issued
Array ( [id] => 16267445 [patent_doc_number] => 20200268932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-27 [patent_title] => CROSSLINKABLE POLYMER COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/523303 [patent_app_country] => US [patent_app_date] => 2019-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10132 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16523303 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/523303
CROSSLINKABLE POLYMER COMPOSITIONS Jul 25, 2019 Abandoned
Array ( [id] => 17154769 [patent_doc_number] => 20210315820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => LIPID NANOPARTICLE FORMULATIONS COMPRISING NUCLEIC ACID MIMICS [patent_app_type] => utility [patent_app_number] => 17/264133 [patent_app_country] => US [patent_app_date] => 2019-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22987 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -134 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264133 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/264133
LIPID NANOPARTICLE FORMULATIONS COMPRISING NUCLEIC ACID MIMICS Jul 24, 2019 Abandoned
Array ( [id] => 17140256 [patent_doc_number] => 20210308267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => REJUVENATION OF CAR T CELL [patent_app_type] => utility [patent_app_number] => 17/266509 [patent_app_country] => US [patent_app_date] => 2019-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8823 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17266509 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/266509
REJUVENATION OF CAR T CELL Jul 20, 2019 Abandoned
Array ( [id] => 15493031 [patent_doc_number] => 20200046704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-13 [patent_title] => SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION [patent_app_type] => utility [patent_app_number] => 16/511210 [patent_app_country] => US [patent_app_date] => 2019-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5469 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16511210 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/511210
Sustained release small molecule drug formulation Jul 14, 2019 Issued
Array ( [id] => 19104617 [patent_doc_number] => 11957690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-16 [patent_title] => Chromogenic beta-lactamase substrate [patent_app_type] => utility [patent_app_number] => 17/260894 [patent_app_country] => US [patent_app_date] => 2019-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 21 [patent_no_of_words] => 11027 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17260894 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/260894
Chromogenic beta-lactamase substrate Jul 14, 2019 Issued
Array ( [id] => 15360805 [patent_doc_number] => 20200016167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => Methods for Treating Hyperbilirubinemia with Stannsoporfin [patent_app_type] => utility [patent_app_number] => 16/505295 [patent_app_country] => US [patent_app_date] => 2019-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33719 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16505295 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/505295
Methods for Treating Hyperbilirubinemia with Stannsoporfin Jul 7, 2019 Abandoned
Array ( [id] => 15239515 [patent_doc_number] => 20190374543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-12 [patent_title] => Therapeutic Combinations of an Antifolate and a BTK Inhibitor [patent_app_type] => utility [patent_app_number] => 16/502545 [patent_app_country] => US [patent_app_date] => 2019-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66152 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502545 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/502545
Therapeutic Combinations of an Antifolate and a BTK Inhibitor Jul 2, 2019 Abandoned
Menu